ESC & iPSC News Volume 17.45 | Nov 23 2022

    0
    63








    2022-11-23 | ESC & iPSC 17.45


    ESC & iPSC News by STEMCELL Technologies
    Vol. 17.45 – 23 November, 2022
    TOP STORY

    An RNAi Screen of RNA Helicases Identifies eIF4A3 as a Regulator of Embryonic Stem Cell Identity

    Starting from an RNA interference (RNAi) screen of RNA helicases, investigators identified that eIF4A3, a DEAD-box helicase component of the exon junction complex, was essential for the maintenance of ESCs.
    [Nucleic Acids Research]

    Full Article
    Listen to the Stem Cell Podcast episodes covering ISSCR 2022 sessions.
    PUBLICATIONSRanked by the impact factor of the journal

    Synthetic Gene Circuits for Cell State Detection and Protein Tuning in Human Pluripotent Stem Cells

    Synthetic gene circuits with sense-and-respond capabilities were designed to detect cell states and perform cell-state-specific control of desired protein expression in hPSCs.
    [Molecular Systems Biology]

    Full ArticleGraphical Abstract

    Surface Engineering of Auxetic Scaffolds for Neural and Vascular Differentiation from Human Pluripotent Stem Cells

    Six different auxetic polyurethane foams with different elastic modulus and Poisson’s ratio were used to investigate lineage specification of hiPSCs.
    [Advanced Healthcare Materials]

    Abstract

    BNIP3-Dependent Mitophagy Safeguards ESC Genomic Integrity via Preventing Oxidative Stress-Induced DNA Damage and Protecting Homologous Recombination

    Researchers showed that BNIP3-dependent mitophagy protected genomic integrity in mESCs. Deletion of Bnip3 increased cellular reactive oxygen species and decreased ATP generation.
    [Cell Death & Disease]

    Full Article

    Analysis of Influenza A Virus Infection in Human Induced Pluripotent Stem Cells (hiPSCs) and Their Derivatives

    Scientists showed that hiPSCs and hiPSC-derived ectodermal, mesodermal, and endodermal cells were susceptible to Influenza A virus (IAV) infection. These cell types stained positive for α2,6-linked sialic acid, the receptor for IAV infection expressed on the cell surface.
    [Virus Research]

    Full Article

    Balance between Autophagy and Cell Death Is Maintained by Polycomb-Mediated Regulation during Stem Cell Differentiation

    During retinoic acid-mediated differentiation of mESCs, autophagy was induced, and the Polycomb group histone methyl transferase EZH2 was identified as a regulator of this process.
    [The FEBS Journal]

    Abstract

    Suppression of YAP Safeguards Human Naïve Pluripotency

    The authors showed that naïve PSCs depleted of β-catenin remained dependent on XAV939. XAV939 prevented trophectoderm induction by reducing activation of YAP.
    [Development]

    Abstract

    Simultaneous Depletion of RB, RBL1, and RBL2 Affects Endoderm Differentiation of Human Embryonic Stem Cells

    Investigators generated hESCs lacking retinoblastoma tumor suppressor (RB) family proteins by introducing frameshift mutations in RBL1 and RBL2 genes using the CRISPR/Cas9 technology, and then integrating the short hairpin RNA-expression cassette to knockdown RB upon tetracycline treatment.
    [PLoS One]

    Full Article

    Increased Expression of 6-Phosphofructo-2-Kinase/Fructose 2,6-Bisphosphatase-3 Is Required for Growth of Mouse Embryonic Stem Cells That Are Undergoing Differentiation

    6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoenzyme expressions were analyzed in R1 and J1 mESCs that were cultured in the presence and absence of leukemia inhibitory factor.
    [Cytotechnology]

    Abstract
    An ISSCR 2022 Innovation Showcase Webinar: Robust Workflows for the Expansion of PSCs in 3D Suspension Culture, presented by Dr. Eric Jervis. Click to Watch Now.
    REVIEWS

    Using Pluripotent Stem Cells to Understand Normal and Leukemic Hematopoietic Development

    The authors review the state of the art of the use of PSCs as a model for hematopoietic and leukemia development.
    [Stem Cells Translational Medicine]

    Full Article

    Mitochondrial Dysfunction of Induced Pluripotent Stem Cells-Based Neurodegenerative Disease Modeling and Therapeutic Strategy

    Scientists summarize the iPSC modeling approach of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, as well as outline typical mitochondrial dysfunction and recapitulate corresponding therapeutic strategies.
    [Frontiers in Cell and Developmental Biology]

    Full Article
    INDUSTRY AND POLICY NEWS

    Prepaireâ„¢ Announces Partnership with Ncardia to Accelerate Plans to Discover New Drugs and Repurpose Existing Libraries

    Prepaireâ„¢ Labs and Ncardia announced the signing of a 5-year agreement. The potential outcome of this partnership will accelerate aspects of drug discovery and development, including target discovery, lead optimization, toxicity assessment, and trial design.
    [Prepaire (EIN Presswire)]

    Press Release
    FEATURED EVENT

    Cell Therapy Analytics Symposium

    September 19, 2023
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Cancer/Stem Cell Biology

    City of Hope – Los Angeles, California, United States

    PhD positions – EuReCa PhD Program

    Institut Curie – Paris, France

    Postdoctoral Position – Cell Competition in Human In Vitro Systems

    University of Bristol – Bristol, England, United Kingdom

    Senior Program Associate – Science in the City

    STEMCELL Technologies, Inc. – Boston, Massachusetts, United States

    Postdoctoral Research Scientist – Molecular Regulation of Human Embryos

    Babraham Institute – Babraham, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    ESC & iPSC News Twitter